Aids - HIV | Research and Innovation

© franz massard #186699440, source: fotolia.com 2018

Combined vaccine strategy targets both hepatitis C virus and HIV

An EU-funded project developed a simple, affordable and effective vaccine strategy to prevent the incidence of both hepatitis C virus and HIV-1. This could significantly increase the life expectancy of people receiving antiretroviral therapy for HIV-1.

Add to pdf basket

HIV study finds no sign of accelerated ageing

Do people living with HIV age more quickly, despite the fact that their infection is well controlled? Concerns have emerged in recent years, and an EU-funded study was launched to look into the matter by exploring links with age-related conditions, with a specific focus on cognitive impairment. No acceleration was observed.

Add to pdf basket

New production method to cut costs of meningitis drugs

The weakened immune system in people with HIV/AIDS makes them particularly vulnerable to fungal infections such as cryptococcal meningitis, which can be deadly. The medicine used to treat the condition is flucytosine, and EU-funded researchers have developed a new and more efficient way of producing it. This will cut production costs, making it more affordable for people in low-income countries.

PDF Basket

No article selected

Filter stories

Country

Theme

Framework programme

Project acronym

Project number

Project coordinator

Project start date

Project end date